The 2060 Longevity Forum

30th - 31st of August 2025, Aix-en-Provence, South of France.
One of the most beautiful and longevity friendly places in the world.


We bring investors, longevity entrepreneurs, scientists and policy makers together to discuss why Longevity is the best Investment Opportunity of Modern Times.

Human longevity is the best investment opportunity
in the history of humanity

Just think for a second, how much would anyone be willing to pay to live longer and healthier?

Market size

This burgeoning anti-aging and longevity sector is poised for explosive growth, with a projected market value of $367 billion by 2032, driven by a compound annual growth rate of 30+%, according to Research & Markets.

Backed by billionaires and institutional investors, the industry is spearheaded by trailblazers conducting groundbreaking research aimed at halting aging and, perhaps, rewriting the very concept of mortality. Visionaries such as Jeff Bezos, Peter Thiel, Larry Ellison, and Larry Page, along with companies like Alphabet, are pouring resources into a field where science meets ambition.

At the forefront of this movement are organizations like the Methuselah Foundation, Juvenescence and BioSplice Therapeutics, exploring solutions from cellular reprogramming and gene therapy to cyborg technology and regenerative medicine. With approaches like cryonics, mind uploading, and young-blood transfusions, these pioneers are redefining possibilities. As big names and investments converge, the longevity revolution marks a new era in human potential.

Science is closer than ever to cracking the code of human biology

We are the first generation of Humans for whom Defeating diseases and slowing down,
stopping or even reversing the process of aging itself has become an audacious yet realistic goal

In 2009, Japanese scientist Yamanaka discovered the OSKM factors, genes that can rejuvenate cells to a youthful state. This breakthrough earned him the Nobel Prize in 2012 and spurred significant advancements in cellular reprogramming .

This discovery, together with other promising technologies (cryopreservation, organ replacement, xenotransplantation, 3D organ printing, gene therapies, etc..) brought us closer than ever to defeating aging.

The pace of biotechnology and preventative medicine is being accelerated even more by Artificial Intelligence. Currently, many ongoing R&D projects address the topic of massively parallel "in silico" drug discovery, some of them reliably testing 1 billion molecules / day.

Speakers

Meet the visionary speakers attending the 2060 longevity forum

Abdul Abakir

Abdul Abakir

Sr. scientist @ Altos Labs

Patrick Burgermeister

Patrick Burgermeister

Managing Director @ RegenEra ventures

Gabriel Cian

Gabriel Cian

Co-founder Ikare.health | President 2060 foundation

Breanna Deutsch

Breanna Deutsch

Secretary of the Board @ The Alliance for Longevity Initiatives

Colwyn Headley, PhD

Colwyn Headley, PhD

Instructor of Cardiovascular Medicine @ Stanford University, Research Consultant in Immune, Cardiovascular & Mitochondrial Health.

Niccolò Invidia

Niccolò Invidia

Aeon Foundation Co-Founder and former member of the Italian Parliament

Sergey Jakimov

Sergey Jakimov

Managing Partner at LongeVC; Co-Founder/Board Member at Longenesis

Brian Kennedy

Brian Kennedy

Director, Centre for Healthy Longevity

Aksana Labokha

Aksana Labokha

CSO @ Centenara Labs

Vladimir Leshko

Vladimir Leshko

COO Unlimited Bio | Biomedical Engineer | Vitalist

Robin Mansukhani

Robin Mansukhani

CEO @ Deciduous Therapeutics

Ole Mensching

Ole Mensching

Co-Founder and General Partner @ Apollo Ventures

Fiona Miller

Fiona Miller

Managing Partner at quadraScope Ventures & Board member @ HealthyLongevity.clinic

Bryan Ngo

Bryan Ngo

Founder and CEO of Post Translational Medicines

Ines O'Donovan

Ines O'Donovan

Co-founder @ Women Leading Longevity Club

Liz Parrish

Liz Parrish

CEO of BioViva USA

Shahaf Peleg

Shahaf Peleg

Group leader at FBN and co-founder of Luminova Biotech

Linus Petersson

Linus Petersson

Co-founder Swedish Longevity Cluster

Jack Scannell

Jack Scannell

CEO, Etheros Pharmaceuticals Corp.

Raghav Sehgal

Raghav Sehgal

Director of Data Science at Healthy Longevity Clinics

Stasa Stankovic

Stasa Stankovic

Co-founder & CEO at OvartiX | Reshaping Drug Discovery for Women's Health

Andrew Steele

Andrew Steele

Author of Ageless: The new science of getting older without getting old

Alexey Strygin

Alexey Strygin

Co-founder Longevity Economics Institute

Maximilian Unfried

Maximilian Unfried

Rejuvenation Biotech | Aging Biology | Bioinformatics

Experience

The Forum

The Forum

The 2-day 2060 Longevity Forum aspires to highlight the investment opportunity of the longevity industry and showcase exciting talks from start-ups, investors and partners. The event will take place from 9am to 6pm, with evening cocktail events to follow. Full programme coming soon.

Health Optimization

Health Optimization

Alongside the events, you'll have exclusive access to a curated selection of health optimization activities, workshops, and immersive experiences. From natural thermal spas and fresh, nutrient-rich cuisine to outdoor living and a strong sense of community, come join us to discover the longevity-friendly charm of Aix-en-Provence.

Venue

setclub, 1 335 chemin de Granet – 13090 Aix-en-Provence.
A beautifully designed environment for networking, socialising and relaxation

Set Club Venue

Join us at the 2060 Longevity Forum

The 2060 Longevity Forum is a non profit organisation.
Your membership helps us in our mission and gets re-invested to contribute to accelerating scientific breakthroughs in longevity.

2-Day Pass

Join us the 30th and 31st of August 2025 for 2 days of networking, talks and investment opportunities.

What’s included

  • 2-Day Access
  • Networking events
  • Access to setclub facilities
  • Early investment opportunities

$1990USD

Get ticket

If the price is holding you back, get in touch—we’d love to help

Partners

LifespanLBFattitudevitadao

Logistics